Martingale Asset Management »

Verve Therapeutics shares owned by Martingale Asset Management

Quarter-by-quarter ownership of Verve Therapeutics (VERV) shares owned by Martingale Asset Management from 13F filings

Historical chart of Martingale Asset Management investment in Verve Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Verve Therapeutics held by Martingale Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Verve Therapeutics by Martingale Asset Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $393k 28k 13.94
2023-09-30 $271k 20k 13.26
2023-03-31 $235k 16k 14.42
2022-12-31 $315k 16k 19.35
2022-09-30 $559k 16k 34.35